Form Blends

GLP-1 & peptide care. Studies, science and FormBlends programs. Automated posts managed by FormBlends. Education, not personal medical advice.

[Form Blends @GetFormBlends]

New here, so the short version:

GLP-1s and peptides, done right. Real scripts, compounded by a LegitScript-certified US 503A pharmacy. No gray market, no mystery vials.

Straight-talk science on metabolic health and longevity.

[Form Blends @GetFormBlends]

Your dispensing pharmacy shouldn't be a mystery. For FormBlends prescriptions, it's named on the label and shipping paperwork. Our guide explains how to check its license. Compounded medicines aren't FDA-approved.
https://t.co/kEsHDYzSeN

[Form Blends @GetFormBlends]

Put a medicinal chemist and a patient advocate on the same stage at the next peptide-research conference. We'd stay for that Q&A.

[American Diabetes Association - DiabetesPro @ADA_DiabetesPro]

This #AmericanDiabetesMonth, we're celebrating healthcare professionals advancing person-centered obesity care. Keep making a difference with insights on addressing weight bias and improving care. 🔗 Download and save this resource for future reference: https://t.co/SBkjcLGQ0P

[Form Blends @GetFormBlends]

Two tongue-twisters, two useful questions. Pharmacokinetics asks what the body does to a medicine; pharmacodynamics asks what the medicine does in the body. NIGMS explains the distinction behind peptide research.
https://t.co/qKNO05qxCx

[Form Blends @GetFormBlends]

2023 RAISE: zilucoplan improved daily-activity scores vs placebo at 12 weeks in 174 adults with AChR-positive generalized myasthenia gravis. Injection-site bruising was common. Serious meningococcal infection is a boxed-warning risk.
https://t.co/iIohhOjDVg

[OAC @ObesityAction]

The Affordable Care Act (ACA) Marketplace Open Enrollment period is here! Compare 2027 plans and review coverage for obesity medications, treatment services, providers and out-of-pocket costs. Know what to look for before enrolling. Read OAC’s blog: https://t.co/aTjLeyzqBl

#ACAOpenEnrollment #AccessToCare #KnowYourCoverage

[Form Blends @GetFormBlends]

A subway map of peptide research would be excellent wall art. Molecules, targets, trial phases. Yes, this is our idea of decor.

[Form Blends @GetFormBlends]

Peptide research has quite a Nobel history. The Endocrine Society's list includes Rosalyn Yalow's 1977 award for developing peptide-hormone radioimmunoassays. Measuring a signal can be a breakthrough, too.
https://t.co/jnIiwzvcrc

[Form Blends @GetFormBlends]

A1C puts a few months of blood sugar into one number. NIDDK explains what it measures, why recent weeks count more, and when results can be misleading. Handy background for reading a GLP-1 diabetes trial.
https://t.co/Mp7r0TDFQ2

[EASD @EASDnews]

🔬 Applications are now open for the #EFSD & Novo Programme for Diabetes Research in Europe from researchers at non-profit institutions in 🇪🇺 & associated countries working on innovative #diabetes #research projects.

📅Deadline: 1 Feb 2027

Apply now👉 https://t.co/rx2IH5Yc54

[Form Blends @GetFormBlends]

Tiny cut, shorter signal. DPP-4 clips two amino acids from the body's GLP-1 and GIP hormones, helping inactivate them. This 2016 RCSB guide explains the enzyme's role in incretin biology.
https://t.co/EOeCJaDgkR

[Form Blends @GetFormBlends]

KALM-1 (2019): difelikefalin reduced itching vs placebo at 12 weeks in 378 adults on hemodialysis with moderate-to-severe itching. Diarrhea, dizziness and vomiting were more common; falls are also a known risk.
https://t.co/kRai13D18H

[EASD @EASDnews]

🎥Missed a session at #EASD2026 or want to rewatch your favourite talks?

Explore 1,000s of presentations, resources, recordings & e-posters from the 62nd EASD Annual Meeting in Milan - now available for free in our EASD Media Centre.

🔗👉 https://t.co/V8F3ckIqPt

#Diabetes

[Form Blends @GetFormBlends]

Put the trial sponsor in the study summary. A promising peptide result can share the page with who paid for it.

[Form Blends @GetFormBlends]

An approval has a paper trail. The FDA's drug database includes approval letters and scientific reviews, alongside labels. Useful reading behind a GLP-1 milestone; document coverage is fuller for drugs approved since 1998.
https://t.co/NtxKSQV3pm

[Form Blends @GetFormBlends]

More frequent bowel movements, less straining. In a 2017 trial in adults with chronic idiopathic constipation, plecanatide beat placebo over 12 weeks. Diarrhea, sometimes severe, is a risk; benefits faded after stopping.
https://t.co/lua4p1lnrN

[American Diabetes Association - DiabetesPro @ADA_DiabetesPro]

How do automated insulin delivery (AID) systems work? Our new resource hub offers practical information for the people you care for. Explore the hub https://t.co/RBVbsR2j7x.

[Form Blends @GetFormBlends]

More head-to-head GLP-1 trials, please. When several treatments look promising, comparing them directly is a damn good next question.

[Form Blends @GetFormBlends]

Randomization, placebo, protocol. NIH's glossary explains the vocabulary packed into trial reports. A useful tab to keep open while reading a GLP-1 paper.
https://t.co/QtRKDm8f0C

[Form Blends @GetFormBlends]

Glucagon has a docking station. This illustrated RCSB guide explains how its receptor catches the hormone and passes the signal into a cell. The overview is a model assembled from several structures, not a single molecular snapshot.
https://t.co/ELjyo31Ai7